ClinicalTrials.gg
Not yet recruitingNCT07807215LaserOpenUpdated Sep 10, 2026

Laser Assisted Open Flap Debridement

An interventional study of Mechanical Open Flap debridement and Laser assisted open flap debridement in Periodontal Disease and Periodontal Bone Loss, sponsored by University of Bari Aldo Moro. Not yet recruiting at 1 site in Italy. Per ClinicalTrials.gov, last updated 2026-09-10.

Primary conditionAlveolar Bone LossRegistry: Periodontal DiseasesReclassifiedWhy we changed it
Registry
Periodontal Diseases — the first condition term the registry derived for this study.
ClinicalTrials.gg
Alveolar Bone Loss
Why
  1. The study's listed conditions name Alveolar Bone Loss, a narrower term within Periodontal Diseases.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Bari Aldo Moro · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Sex
All
01

Study summary

The study involves the surgical treatment of patients with Stage I to III of periodontitis. Following completion of Steps 1 and 2 of periodontal therapy according to the EFP guidelines for the treatment of periodontitis, sites presenting with residual probing depths greater than 5 mm and non-contained periodontal defects will undergo open-flap debridement and decontamination.

In one group, debridement and decontamination will be performed using manual and ultrasonic instrumentation, whereas in the other group, the same treatment will be supplemented with laser therapy.

02

Conditions studied

  • Periodontal Disease
  • Periodontal Bone Loss

Browse trials for

Keywords

  • Periodontitis
  • Laser
  • Open Flap
  • Minimally invasive
  • Coagulation
  • decontamination
03

In context

Alveolar Bone Loss Reclassified

318 studies on the registry are indexed under Alveolar Bone Loss; 79 are open to participants now.

This study's planned enrollment of 20 is below the median of 25 across 269 interventional studies indexed under Alveolar Bone Loss.

Browse Alveolar Bone Loss studies →

Lead sponsor

University of Bari Aldo Moro is the lead sponsor of 30 studies on the registry; 13 are open to participants now.

Compared within Alveolar Bone Loss, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Periodontal Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults in good general health
  • Signed
  • Periodontal disease treated with non surgical step.

Exclusion criteria

Exclusion Criteria:

  • Systemic conditions affecting bone healing
  • Uncontrolled periodontal disease
  • Smoking >10 cigarettes/day
  • Pregnancy or lactation
  • Use of medications interfering with bone metabolism
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Mechanical Open Flap debridement

    Patients with periodontal defects ( more than 5 mm probing after step I and II). Intervention: Following flap elevation, the defects will be instrumented using manual and ultrasonic instruments.

    Procedure: Mechanical Open Flap debridement

  • Experimental
    Laser assisted open Flap debridement

    The defects will be instrumented using manual and ultrasonic instruments follow by laser debridement and decontamination of the pockets.

    Procedure: Laser assisted open flap debridement

Interventions

  • ProcedureMechanical Open Flap debridement

    Open-flap debridement will be performed under local anesthesia. Following incisions, a full-thickness mucoperiosteal flap will be elevated to provide adequate access to the periodontal defect and root surfaces. Granulation tissue will be carefully removed, and thorough root surface debridement will be performed using manual and ultrasonic devices. After instrumentation surgical site, the flap will be repositioned and stabilized with sutures to achieve appropriate wound closure.

    Also known as: Periodontal flap surgery, Access flap surgery

  • ProcedureLaser assisted open flap debridement

    Open-flap debridement will be performed under local anesthesia. Following intrasulcular incisions, a full-thickness mucoperiosteal flap will be elevated to provide adequate access to the periodontal defect and root surfaces. Granulation tissue will be carefully removed, and thorough root surface debridement will be performed using manual and ultrasonic instrumentation. In the test group, laser irradiation will subsequently be performed within the periodontal pocket and on the exposed root surface as an adjunctive decontamination procedure. After instrumentation, laser treatment, and irrigation of the surgical site, the flap will be repositioned and stabilized with sutures to achieve appropriate wound closure.

    Also known as: Laser assisted Periodontal surgery

06

What researchers measure

Primary outcomes

  1. Periodontal probing depth

    Will be measured with dental prob the probing depth before 3 month of the surgery

    Time frame: 3 month

Secondary outcomes

  1. Bleeding on probing

    The % os BoP will be value after 3 months.

    Time frame: 3 month

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Sep 2026; primary completion for Oct 2026, 1 month later.

Of 167 non-industry interventional studies with no phase under Alveolar Bone Loss, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 30. This study's planned 1 month is below that.

Counting every sponsor, half of 167 studies reached it within 18 months; a quarter within 11 and three quarters within 30.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 2, 2026
First posted
Sep 8, 2026
StartEst.
Sep 10, 2026
Primary completionEst.
Oct 10, 2026
CompletionEst.
Nov 10, 2026
Last update
Sep 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 10, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07807215
Lead sponsor
University of Bari Aldo Moro
Responsible party
Giuseppe D'Albis (Principal investigator, University of Bari Aldo Moro) — Principal investigator
First posted
Sep 8, 2026
Start date
Sep 10, 2026 (estimated)
Primary completion
Oct 10, 2026 (estimated)
Completion
Nov 10, 2026 (estimated)
Last update
Sep 10, 2026

Study contacts

Giuseppe D'Albis, Dr.
Contact
giuseppe.dalbis@uniba.it
3495103642
Mattia Marra, Dr.
Contact
mattiamarra21@gmail.com
Giuseppe D'Albis, Dr
principal investigator · University of Bari Aldo Moro
Mattia Marra, Dr
principal investigator · University of Bari Aldo Moro
Saverio Capodiferro, Prof
study director · University of Bari Aldo Moro

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion